The Role of Real World Evidence in Regulatory Decision Making

The NHC and the Duke-Margolis Center for Health Policy training series introducing RWD and RWE continues with "The Role of Real-World Evidence in Regulatory Decision-Making." Speakers include Mark McClellan, MD, PhD, Director, Duke-Margolis Center for Health Policy and Robert J. Margolis Professor of Business, Medicine, and Policy; Nancy Dreyer, PhD, MPH, Chief Scientific Officer and Senior Vice President, IQVIA; and Jie (Jenni) Li, PhD, Associate Director for RWE, Office of Surveillance and Epidemiology, CDER FDA.